. (BXLT)
$46.02 - (-)
Market Cap: -
As of 09/20/16 12:00 AM EDT. Market closed.
. (BXLT)
$46.02
- (-)
Market Cap: -
As of 09/20/16 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$46.02
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$46.02
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
FORSYTH JOHN D | Director | Mar 24, 2016 | Option Exercise | $17.97 | 5,660 | 101,710 | 28,984 | Mar 28, 2016, 04:33 PM |
FORSYTH JOHN D | Director | Mar 24, 2016 | Sale | $39.97 | 5,660 | 226,230 | 23,324 | Mar 28, 2016, 04:33 PM |
STROUCKEN ALBERT P L | Director | Mar 24, 2016 | Option Exercise | $17.96 | 5,660 | 101,654 | 26,415 | Mar 28, 2016, 04:32 PM |
STROUCKEN ALBERT P L | Director | Mar 24, 2016 | Sale | $39.98 | 5,660 | 226,287 | 20,755 | Mar 28, 2016, 04:32 PM |
GAVIN JAMES R III | Director | Mar 24, 2016 | Option Exercise | $17.97 | 5,660 | 101,710 | 32,003 | Mar 28, 2016, 04:31 PM |
GAVIN JAMES R III | Director | Mar 24, 2016 | Sale | $39.97 | 5,660 | 226,230 | 26,343 | Mar 28, 2016, 04:31 PM |
LEONARDI JACOPO | EVP and President, Immunology | Mar 07, 2016 | Option Exercise | $39.74 | 87 | 3,457 | 55,041 | Mar 08, 2016, 04:58 PM |
GLASSPOOL JOHN | See Remarks | Mar 07, 2016 | Option Exercise | $39.74 | 154 | 6,120 | 39,435 | Mar 08, 2016, 04:57 PM |
MCCOY JOHN A. | SVP and Controller | Mar 07, 2016 | Option Exercise | $39.74 | 84 | 3,338 | 24,031 | Mar 08, 2016, 04:56 PM |
Goff Brian | EVP and President, Hematology | Mar 07, 2016 | Option Exercise | $39.74 | 267 | 10,611 | 67,030 | Mar 08, 2016, 04:56 PM |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Mar 03, 2016 | Option Exercise | $39.30 | 982 | 38,593 | 71,137 | Mar 07, 2016, 06:20 PM |
ORLOFF JOHN J | EVP and President, R&D | Mar 03, 2016 | Option Exercise | $39.30 | 1,408 | 55,334 | 96,009 | Mar 07, 2016, 06:18 PM |
HANTSON LUDWIG | Chairman of the Board and CEO | Mar 03, 2016 | Option Exercise | $39.30 | 6,074 | 238,708 | 417,881 | Mar 07, 2016, 06:18 PM |
Meek David D. | EVP and President, Oncology | Mar 03, 2016 | Option Exercise | $39.30 | 928 | 36,470 | 51,586 | Mar 07, 2016, 06:17 PM |
LAW ANNE-MARIE | EVP & Head of Human Resources | Mar 03, 2016 | Option Exercise | $39.30 | 1,171 | 46,020 | 85,139 | Mar 07, 2016, 06:15 PM |
MCCOY JOHN A. | SVP and Controller | Mar 04, 2016 | Option Exercise | $39.47 | 88 | 3,473 | 24,115 | Mar 07, 2016, 06:14 PM |
MCCOY JOHN A. | SVP and Controller | Mar 03, 2016 | Option Exercise | $39.30 | 410 | 16,113 | 24,203 | Mar 07, 2016, 06:14 PM |
HOMBACH ROBERT J. | EVP, CFO and COO | Mar 03, 2016 | Option Exercise | $39.30 | 5,900 | 231,870 | 192,464 | Mar 07, 2016, 06:14 PM |
Goff Brian | EVP and President, Hematology | Mar 04, 2016 | Option Exercise | $39.47 | 303 | 11,959 | 67,297 | Mar 07, 2016, 06:14 PM |
Goff Brian | EVP and President, Hematology | Mar 03, 2016 | Option Exercise | $39.30 | 1,338 | 52,583 | 67,600 | Mar 07, 2016, 06:14 PM |
GLASSPOOL JOHN | See Remarks | Mar 04, 2016 | Option Exercise | $39.47 | 161 | 6,355 | 39,589 | Mar 07, 2016, 06:12 PM |
GLASSPOOL JOHN | See Remarks | Mar 03, 2016 | Option Exercise | $39.30 | 859 | 33,759 | 39,750 | Mar 07, 2016, 06:12 PM |
LEONARDI JACOPO | EVP and President, Immunology | Mar 03, 2016 | Option Exercise | $39.30 | 584 | 22,951 | 55,237 | Mar 07, 2016, 06:11 PM |
LEONARDI JACOPO | EVP and President, Immunology | Mar 04, 2016 | Option Exercise | $39.47 | 109 | 4,302 | 55,128 | Mar 07, 2016, 06:11 PM |
LAW ANNE-MARIE | EVP & Head of Human Resources | Mar 02, 2016 | Option Exercise | $39.90 | 4,175 | 166,583 | 53,248 | Mar 04, 2016, 04:46 PM |
Devitt Blake E | Director | Feb 25, 2016 | Buy | $39.17 | 5,900 | 231,103 | 27,965 | Feb 29, 2016, 04:50 PM |
HOMBACH ROBERT J. | EVP, CFO and COO | Feb 15, 2016 | Option Exercise | $39.00 | 4,066 | 158,574 | 114,095 | Feb 17, 2016, 09:11 PM |
Goff Brian | EVP and President, Hematology | Feb 15, 2016 | Option Exercise | $39.00 | 533 | 20,787 | 32,827 | Feb 17, 2016, 09:10 PM |
GLASSPOOL JOHN | See Remarks | Feb 15, 2016 | Option Exercise | $39.00 | 353 | 13,767 | 25,094 | Feb 17, 2016, 09:05 PM |
MCCOY JOHN A. | SVP and Controller | Feb 15, 2016 | Option Exercise | $39.00 | 208 | 8,112 | 14,289 | Feb 17, 2016, 09:05 PM |
HANTSON LUDWIG | President and CEO | Feb 15, 2016 | Option Exercise | $39.00 | 6,238 | 243,282 | 217,612 | Feb 17, 2016, 09:02 PM |
LEONARDI JACOPO | EVP and President, Immunology | Feb 15, 2016 | Option Exercise | $39.00 | 208 | 8,112 | 27,665 | Feb 17, 2016, 09:01 PM |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Dec 01, 2015 | Option Exercise | $34.63 | 6,893 | 238,705 | 56,737 | Dec 07, 2015, 07:49 PM |
GLASSPOOL JOHN | See Remarks | Dec 03, 2015 | Option Exercise | $34.98 | 1,746 | 61,075 | 24,975 | Dec 04, 2015, 08:46 PM |
LEONARDI JACOPO | EVP and President, Immunology | Dec 03, 2015 | Option Exercise | $34.98 | 835 | 29,208 | 27,505 | Dec 04, 2015, 08:45 PM |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Dec 01, 2015 | Option Exercise | $34.63 | 6,893 | 238,705 | 11,610 | Dec 03, 2015, 06:18 PM |
Meek David D. | EVP and President, Oncology | Sep 02, 2015 | Option Exercise | $35.03 | 791 | 27,709 | 24,277 | Sep 04, 2015, 04:11 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
FORSYTH JOHN D | Director | 03/24/2016 | 101,710 |
FORSYTH JOHN D | Director | 03/24/2016 | 226,230 |
STROUCKEN ALBERT P L | Director | 03/24/2016 | 101,654 |
STROUCKEN ALBERT P L | Director | 03/24/2016 | 226,287 |
GAVIN JAMES R III | Director | 03/24/2016 | 101,710 |
GAVIN JAMES R III | Director | 03/24/2016 | 226,230 |
LEONARDI JACOPO | EVP and President, Immunology | 03/07/2016 | 3,457 |
GLASSPOOL JOHN | See Remarks | 03/07/2016 | 6,120 |
MCCOY JOHN A. | SVP and Controller | 03/07/2016 | 3,338 |
Goff Brian | EVP and President, Hematology | 03/07/2016 | 10,611 |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | 03/03/2016 | 38,593 |
ORLOFF JOHN J | EVP and President, R&D | 03/03/2016 | 55,334 |
HANTSON LUDWIG | Chairman of the Board and CEO | 03/03/2016 | 238,708 |
Meek David D. | EVP and President, Oncology | 03/03/2016 | 36,470 |
LAW ANNE-MARIE | EVP & Head of Human Resources | 03/03/2016 | 46,020 |
MCCOY JOHN A. | SVP and Controller | 03/04/2016 | 3,473 |
MCCOY JOHN A. | SVP and Controller | 03/03/2016 | 16,113 |
HOMBACH ROBERT J. | EVP, CFO and COO | 03/03/2016 | 231,870 |
Goff Brian | EVP and President, Hematology | 03/04/2016 | 11,959 |
Goff Brian | EVP and President, Hematology | 03/03/2016 | 52,583 |
GLASSPOOL JOHN | See Remarks | 03/04/2016 | 6,355 |
GLASSPOOL JOHN | See Remarks | 03/03/2016 | 33,759 |
LEONARDI JACOPO | EVP and President, Immunology | 03/03/2016 | 22,951 |
LEONARDI JACOPO | EVP and President, Immunology | 03/04/2016 | 4,302 |
LAW ANNE-MARIE | EVP & Head of Human Resources | 03/02/2016 | 166,583 |
Devitt Blake E | Director | 02/25/2016 | 231,103 |
HOMBACH ROBERT J. | EVP, CFO and COO | 02/15/2016 | 158,574 |
Goff Brian | EVP and President, Hematology | 02/15/2016 | 20,787 |
GLASSPOOL JOHN | See Remarks | 02/15/2016 | 13,767 |
MCCOY JOHN A. | SVP and Controller | 02/15/2016 | 8,112 |
HANTSON LUDWIG | President and CEO | 02/15/2016 | 243,282 |
LEONARDI JACOPO | EVP and President, Immunology | 02/15/2016 | 8,112 |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | 12/01/2015 | 238,705 |
GLASSPOOL JOHN | See Remarks | 12/03/2015 | 61,075 |
LEONARDI JACOPO | EVP and President, Immunology | 12/03/2015 | 29,208 |
ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | 12/01/2015 | 238,705 |
Meek David D. | EVP and President, Oncology | 09/02/2015 | 27,709 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...